North American Report

Non-Hormonal Alternatives for Menopause Market Size Estimated to Reach USD 13,465 Mn By 2028, With 7.5% CAGR: Statistics Report by Credence Research

 Breaking News
  • No posts were found

Non-Hormonal Alternatives for Menopause Market Size Estimated to Reach USD 13,465 Mn By 2028, With 7.5% CAGR: Statistics Report by Credence Research

May 19
20:37 2022
Non-Hormonal Alternatives for Menopause Market Size Estimated to Reach USD 13,465 Mn By 2028, With 7.5% CAGR: Statistics Report by Credence Research
The demand for Non-Hormonal Alternatives for Menopause is likely to exhibit rapid CAGR of over 7.5% over the forecast period to reach the valuation of USD 13,465 million in 2028.

The Global Non-Hormonal Alternatives for Menopause Market generated revenue of around USD 7,929.16 million in 2021 and is anticipated to grow a CAGR of over 7.57% during the forecast period from 2022 to 2028 to reach around USD 13,465.59 million in 2028. While, cumulative growth opportunity presented by the global Non-Hormonal Alternatives for Menopause is around USD 76.6 billion during 2022 to 2028.

Global Non-Hormonal Alternatives for Menopause Market, 2021 – 2028 (USD Million)

Non-Hormonal Alternatives for Menopause has been emerged as an effective replacement of hormonal therapy to be used to treat menopause in women. Large percentage of women face health problems associated with menopause such as mood swings, depression, anxiety, hot flashes, etc. Systemic hormonal therapy has been widely accepted to treat menopause. However, there are certain serious concerns related to hormonal therapy for menopause.

Browse the full report at  https://www.credenceresearch.com/report/non-hormonal-alternatives-for-menopause-market

Hot Flashes to Held the Considerable Share in Global Non-Hormonal Alternatives for Menopause Market

Hot Flashes and Others (Chills, Night Sweats, Sleep Problems, Mood Changes, etc.) are some of the major indication segments of Non-Hormonal Alternatives for Menopause market by indication. Hot Flashes  is major segments by type in Non-Hormonal Alternatives for Menopause market. On the other hand, Chills, Night Sweats, Sleep Problems, Mood Changes, etc. is likely to grow in its market at rapid pace over the forecast period.

Antidepressants to Lead the Growth of Non-Hormonal Alternatives for Menopause Market

Selective serotonin reuptake inhibitors (SSRIs), Selective serotonin-norepinephrine reuptake inhibitors (SNRIs), Plant-derived estrogens (phytoestrogens), Herbal treatments, Over-the-counter therapies and Others are therapies of global Non-Hormonal Alternatives for Menopause. Antidepressants such as  Selective serotonin reuptake inhibitors (SSRIs) and Selective serotonin-norepinephrine reuptake inhibitors (SNRIs) accounted major segment of the Non-Hormonal Alternatives for Menopause industry. While Herbal treatments also held the significant share in Non-Hormonal Alternatives for Menopause in 2021. It accounted for over 20% share in total revenue generated by the global Non-Hormonal Alternatives for Menopause  market in 2021. While, Plant-derived estrogens for Non-Hormonal Alternatives for Menopause is expected exhibit highest CAGR over the forecast period.

Healthy Women to Hold Largest Share of Non-Hormonal Alternatives for Menopause Industry

Healthy Women and Breast cancer survivors are some of the major end-users of Non-Hormonal Alternatives for Menopause. Healthy Women’s segment held over 80% share in total revenue generated by the Non-Hormonal Alternatives for Menopause market across the world. While, Breast cancer survivors’ women segment is going to be the second leading end-user segment for the global Non-Hormonal Alternatives for Menopause market.

U.S. is Leading Non-Hormonal Alternatives for Menopause Demand

U.S. is leading the demand for Non-Hormonal Alternatives for Menopause with Australia, China, South Korea, Japan, UK, France, Germany and Singapore being at the forefront of Non-Hormonal Alternatives for Menopause adoption. Asia Pacific will exhibit the fastest CAGR over the forecast period. Huge investment incurred by the companies and presence of large consumer base for Non-Hormonal Alternatives for Menopause, the demand in the above mentioned regions will be higher in the years to come.

Major players operating in the global Non-Hormonal Alternatives for Menopause  market include Swor Women’s Care, Paladin Labs, Boehringer Ingelheim, Pfizer, Organon Inc., Lupin and GSK. Global Non-Hormonal Alternatives for Menopause market is characterized by the presence of large number of players across the world and is highly fragmented as well.

Inquiry on this Report Before Purchase @ https://www.credenceresearch.com/inquiry-before-buying/60540

Non-Hormonal Alternatives for Menopause Market

Report Attribute

Details

Market Value in 2021

USD 7,929.16 million

Market Value in 2028

USD 13,465.59 million

CAGR

7.57% between 2021 and 2028

Benchmarking Year

2021

Forecast period

2022 – 2028

Report coverage

Market Size Valuation, Share Analysis and Growth Rate by Segments such as Indication and End-user, Company Share, Competitive Landscape and Trends Analysis

Segments covered

Indication

Hot Flashes

Others

End-user

Health Women

Breast cancer survivors

Therapy

Selective serotonin reuptake inhibitors (SSRIs)

Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)

Plant-derived estrogens (phytoestrogens)

Herbal treatments

Over-the-counter therapies

Others

Major Players Analysed

Salted Venture, Adidas, Digitsole, Pepper Gate Footwear Inc., PUMA SE (KERING), Xiaomi Corporation Limited, Zhor-Tech, Nike, Inc., ShiftWear, TRAQshoes, Under Armour, Inc. and Vivobarefoot Limited

Cost of the Report

Write us at [email protected]

Sample of report with TOC @ https://www.credenceresearch.com/sample-request/60540

Market Segmentation

Global Non-Hormonal Alternatives for Menopause Market by Indication, 2016 – 2028

  • Hot Flashes
  • Others (Chills, Night Sweats, Sleep Problems, Mood Changes, etc.)

Global Non-Hormonal Alternatives for Menopause Market by Therapy, 2016 – 2028

  • Selective serotonin reuptake inhibitors (SSRIs)
  • Selective serotonin-norepinephrine reuptake inhibitors (SNRIs)
  • Plant-derived estrogens (phytoestrogens)
  • Herbal treatments
  • Over-the-counter therapies
  • Others

Global Non-Hormonal Alternatives for Menopause Market by Application, 2016 – 2028

  • Health Women
  • Breast cancer survivors

Global Non-Hormonal Alternatives for Menopause Market by Company, 2016 – 2028

  • Swor Women’s Care
  • Paladin Labs
  • Boehringer Ingelheim
  • Pfizer
  • Organon Inc.,
  • Lupin
  • GSK
  • Others

Browse the full report at  https://www.credenceresearch.com/report/non-hormonal-alternatives-for-menopause-market

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, nonlegislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact
Company Name: Credence Research
Contact Person: Chris Smith
Email: Send Email
Phone: 18003618290
City: SAN JOSE
State: CA
Country: United States
Website: https://www.credenceresearch.com/